Karin E. de Visser

20.0k total citations · 8 hit papers
80 papers, 11.7k citations indexed

About

Karin E. de Visser is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Karin E. de Visser has authored 80 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Immunology, 50 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Karin E. de Visser's work include Cancer Immunotherapy and Biomarkers (30 papers), Immune cells in cancer (29 papers) and Immunotherapy and Immune Responses (26 papers). Karin E. de Visser is often cited by papers focused on Cancer Immunotherapy and Biomarkers (30 papers), Immune cells in cancer (29 papers) and Immunotherapy and Immune Responses (26 papers). Karin E. de Visser collaborates with scholars based in Netherlands, United States and Germany. Karin E. de Visser's co-authors include Lisa M. Coussens, Johanna A. Joyce, Max D. Wellenstein, Seth B. Coffelt, Alexandra Eichten, Jos Jonkers, Lidiya Korets, Kelly Kersten, Cheei‐Sing Hau and Kim Vrijland and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Karin E. de Visser

80 papers receiving 11.5k citations

Hit Papers

The evolvi... 2005 2026 2012 2019 2023 2006 2016 2015 2005 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
    2023 1.9k citations Karin E. de Visser et al. Cancer Cell profile →
  2. Paradoxical roles of the immune system during cancer development
    2006 1.7k citations Karin E. de Visser et al. Nature reviews. Cancer profile →
  3. Neutrophils in cancer: neutral no more
    2016 1.3k citations Seth B. Coffelt, Max D. Wellenstein et al. Nature reviews. Cancer profile →
  4. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
    2015 1.3k citations Seth B. Coffelt, Kelly Kersten et al. profile →
  5. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
    2005 609 citations Karin E. de Visser et al. Cancer Cell profile →
  6. Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
    2018 413 citations Max D. Wellenstein, Karin E. de Visser profile →
  7. Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
    2019 361 citations Max D. Wellenstein, Seth B. Coffelt et al. profile →
  8. Mechanisms driving the immunoregulatory function of cancer cells
    2023 155 citations Antoinette van Weverwijk, Karin E. de Visser Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin E. de Visser Netherlands 37 5.8k 5.7k 3.7k 2.0k 1.3k 80 11.7k
Keith L. Knutson United States 55 6.7k 1.2× 6.4k 1.1× 4.7k 1.3× 1.7k 0.9× 1.4k 1.1× 187 14.3k
Nathalie Chaput France 45 5.6k 1.0× 5.7k 1.0× 4.5k 1.2× 1.8k 0.9× 1.6k 1.2× 144 11.7k
José R. Conejo-García United States 58 7.2k 1.2× 5.8k 1.0× 5.3k 1.4× 1.7k 0.9× 945 0.7× 208 14.2k
Ann Richmond United States 62 5.4k 0.9× 6.3k 1.1× 5.1k 1.4× 1.9k 1.0× 825 0.6× 166 12.9k
Barbara Seliger Germany 65 8.1k 1.4× 6.3k 1.1× 5.3k 1.4× 1.8k 0.9× 1.4k 1.1× 362 15.2k
Ping‐Chih Ho Switzerland 43 5.3k 0.9× 3.3k 0.6× 3.9k 1.1× 2.5k 1.3× 908 0.7× 112 10.0k
Stefani Spranger United States 40 7.5k 1.3× 7.5k 1.3× 3.7k 1.0× 1.3k 0.7× 1.3k 1.0× 80 12.2k
Taha Merghoub United States 54 6.3k 1.1× 6.9k 1.2× 4.3k 1.2× 1.3k 0.7× 1.2k 0.9× 210 12.5k
Michele W.L. Teng Australia 56 8.3k 1.4× 9.2k 1.6× 3.6k 1.0× 1.4k 0.7× 1.9k 1.4× 95 15.0k
Ena Wang United States 67 7.2k 1.2× 6.3k 1.1× 5.4k 1.4× 2.0k 1.0× 949 0.7× 260 14.2k

Countries citing papers authored by Karin E. de Visser

Since Specialization
Citations

This map shows the geographic impact of Karin E. de Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin E. de Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin E. de Visser more than expected).

Fields of papers citing papers by Karin E. de Visser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin E. de Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin E. de Visser. The network helps show where Karin E. de Visser may publish in the future.

Co-authorship network of co-authors of Karin E. de Visser

This figure shows the co-authorship network connecting the top 25 collaborators of Karin E. de Visser. A scholar is included among the top collaborators of Karin E. de Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin E. de Visser. Karin E. de Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bakker, Noor A. M., Hannah Garner, Ewald van Dyk, et al.. (2025). Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality. npj Breast Cancer. 11(1). 5–5. 4 indexed citations
2.
Garner, Hannah, Ning Qing Liu, Noor A. M. Bakker, et al.. (2025). Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread. Cancer Cell. 43(7). 1279–1295.e9. 9 indexed citations
3.
Blomberg, Olga, Kevin Kos, Lorenzo Spagnuolo, et al.. (2023). Neoadjuvant immune checkpoint blockade triggers persistent and systemic T reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. OncoImmunology. 12(1). 2201147–2201147. 11 indexed citations
4.
Weverwijk, Antoinette van & Karin E. de Visser. (2023). Mechanisms driving the immunoregulatory function of cancer cells. Nature reviews. Cancer. 23(4). 193–215. 155 indexed citations breakdown →
5.
Hassin, Ori, Felix C. E. Vogel, Max D. Wellenstein, et al.. (2023). p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells. Proceedings of the National Academy of Sciences. 120(52). e2311460120–e2311460120. 6 indexed citations
6.
Kos, Kevin, Muhammad Assad Aslam, Rieneke van de Ven, et al.. (2022). Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche. Cell Reports. 38(9). 110447–110447. 39 indexed citations
7.
Pieters, Wietske, Floor Hugenholtz, Kevin Kos, et al.. (2022). Pro-mutagenic effects of the gut microbiota in a Lynch syndrome mouse model. Gut Microbes. 14(1). 2035660–2035660. 7 indexed citations
8.
Bakker, Noor A. M., Jossie Rotman, Marc van Beurden, et al.. (2021). HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial. Journal for ImmunoTherapy of Cancer. 9(8). e002547–e002547. 12 indexed citations
9.
Verbruggen, Bas, Marianna A. Tryfonidou, Alwine B. Kruisselbrink, et al.. (2021). Transformed Canine and Murine Mesenchymal Stem Cells as a Model for Sarcoma with Complex Genomics. Cancers. 13(5). 1126–1126. 7 indexed citations
10.
Duits, Danique E. M. & Karin E. de Visser. (2021). Impact of cancer cell-intrinsic features on neutrophil behavior. Seminars in Immunology. 57. 101546–101546. 16 indexed citations
11.
Garner, Hannah & Karin E. de Visser. (2020). Immune crosstalk in cancer progression and metastatic spread: a complex conversation. Nature reviews. Immunology. 20(8). 483–497. 286 indexed citations
12.
Klarenbeek, Sjoerd, Chris W. Doornebal, Sjors M. Kas, et al.. (2020). Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune system. OncoImmunology. 9(1). 1724049–1724049. 8 indexed citations
13.
Salvagno, Camilla, Metamia Ciampricotti, Cheei‐Sing Hau, et al.. (2019). Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response. Nature Cell Biology. 21(4). 511–521. 122 indexed citations
14.
Blomberg, Olga, Lorenzo Spagnuolo, & Karin E. de Visser. (2018). Immune regulation of metastasis: mechanistic insights and therapeutic opportunities. Disease Models & Mechanisms. 11(10). 99 indexed citations
15.
Kersten, Kelly, Seth B. Coffelt, Marlous Hoogstraat, et al.. (2017). Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages. OncoImmunology. 6(8). e1334744–e1334744. 85 indexed citations
16.
Doornebal, Chris W., Sjoerd Klarenbeek, Tanya M. Braumuller, et al.. (2012). A Preclinical Mouse Model of Invasive Lobular Breast Cancer Metastasis. Cancer Research. 73(1). 353–363. 55 indexed citations
17.
Overwijk, Willem W., Karin E. de Visser, Felicia H. Tirion, et al.. (2006). Immunological and Antitumor Effects of IL-23 as a Cancer Vaccine Adjuvant. The Journal of Immunology. 176(9). 5213–5222. 67 indexed citations
18.
Kessels, Helmut W., Karin E. de Visser, Felicia H. Tirion, et al.. (2004). The Impact of Self-Tolerance on the Polyclonal CD8+ T Cell Repertoire. The Journal of Immunology. 172(4). 2324–2331. 14 indexed citations
19.
Visser, Karin E. de, et al.. (2002). Can the Low-Avidity Self-Specific T Cell Repertoire Be Exploited for Tumor Rejection?. The Journal of Immunology. 168(2). 651–660. 38 indexed citations
20.
Visser, Karin E. de, et al.. (2001). Low-Avidity Self-Specific T Cells Display a Pronounced Expansion Defect That Can Be Overcome by Altered Peptide Ligands. The Journal of Immunology. 167(7). 3818–3828. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith L. Knutson Breakdown of academic impact, for papers by Nathalie Chaput Breakdown of academic impact, for papers by José R. Conejo-García Breakdown of academic impact, for papers by Ann Richmond Breakdown of academic impact, for papers by Barbara Seliger Breakdown of academic impact, for papers by Ping‐Chih Ho Breakdown of academic impact, for papers by Stefani Spranger Breakdown of academic impact, for papers by Taha Merghoub Breakdown of academic impact, for papers by Michele W.L. Teng Breakdown of academic impact, for papers by Ena Wang
Rankless by CCL
2026